Last $0.40 USD
Change Today +0.01 / 2.56%
Volume 527.1K
NSPH On Other Exchanges
Symbol
Exchange
NSPH is not on other exchanges.
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

nanosphere inc (NSPH) Snapshot

Open
$0.39
Previous Close
$0.39
Day High
$0.40
Day Low
$0.38
52 Week High
01/10/14 - $2.97
52 Week Low
12/4/14 - $0.32
Market Cap
46.9M
Average Volume 10 Days
1.0M
EPS TTM
$-0.51
Shares Outstanding
117.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NANOSPHERE INC (NSPH)

Related News

No related news articles were found.

nanosphere inc (NSPH) Related Businessweek News

No Related Businessweek News Found

nanosphere inc (NSPH) Details

Nanosphere, Inc. provides molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment, and enhanced healthcare economics. Its Verigene System platform enables clinicians to identify and treat the bacteria and viruses for complex, costly, and deadly infectious diseases. The Verigene System includes a bench-top molecular diagnostics workstation for genomic and protein testing. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive protein assays. The company focuses on serving hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois.

165 Employees
Last Reported Date: 02/18/14
Founded in 1998

nanosphere inc (NSPH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $330.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $383.1K
Chief Strategy Officer
Total Annual Compensation: $211.0K
Compensation as of Fiscal Year 2013.

nanosphere inc (NSPH) Key Developments

Nanosphere, Inc. Presents at ISI MedTools & Outsourcing Investor Forum, Dec-03-2014

Nanosphere, Inc. Presents at ISI MedTools & Outsourcing Investor Forum, Dec-03-2014 . Venue: Boston Harbor Hotel, Boston, Massachusetts, United States.

Nanosphere, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Revenue Guidance for the Year 2014

Nanosphere, Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported total revenue of $3,688,000 compared to $2,367,000 a year ago. The 56% year-over-year growth was driven by consumable sales that increased by 104%. Loss from operations was $9,261,000 compared to $9,060,000 reported a year ago. Net loss was $9,602,000 or $0.13 per basic and diluted share compared to $9,427,000 or $0.16 per basic and diluted share reported a year ago. The revenue growth was largely driven by bloodstream infection sales. For the nine months, the company reported total revenue of $9,643,000 compared to $6,588,000 a year ago. Loss from operations was $28,551,000 compared to $25,237,000 reported a year ago. Net loss was $29,618,000 or $0.39 per basic and diluted share compared to $25,808,000 or $0.45 per basic and diluted share reported a year ago. Net cash used in operating activities decreased $0.3 million from $26.6 million to $26.3 million for the nine months ended September 30, 2013 and 2014, respectively. For the year 2014, the company expects revenue of $14 million.

Nanosphere, Inc., Q3 2014 Earnings Call, Nov 05, 2014

Nanosphere, Inc., Q3 2014 Earnings Call, Nov 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NSPH:US $0.40 USD +0.01

NSPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GenMark Diagnostics Inc $13.70 USD +0.03
Great Basin Scientific Inc $2.35 USD -0.18
Luminex Corp $18.99 USD +0.39
Meridian Bioscience Inc $16.80 USD +0.12
Quidel Corp $27.78 USD -0.08
View Industry Companies
 

Industry Analysis

NSPH

Industry Average

Valuation NSPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOSPHERE INC, please visit www.nanosphere.us. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.